This inventor holds 4 USPTO granted patents. Top assignees: Laboratorios Almirall, S.a., Anphar, S.a., Fordonal, S.a.. Active years: 1979-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1979-1996
Title: Armando V Noverola: Innovator in Pharmaceutical Chemistry
Introduction
Armando V Noverola is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications. With a total of 4 patents to his name, Noverola's work has the potential to impact the treatment of various medical conditions.
Latest Patents
One of Noverola's latest patents involves indole derivatives, which are compounds useful in the treatment of migraine and other conditions. The patent describes a compound of formula (I) wherein R¹ and R² each represent a hydrogen atom or an alkyl group, and Z represents a specific ring structure. These compounds are prepared by the decarboxylation of the corresponding indolyl 2-carboxylic acid. Additionally, he has worked on xanthine compounds and compositions, along with methods of using them.
Career Highlights
Throughout his career, Noverola has been associated with several prominent companies in the pharmaceutical industry. Notably, he has worked with Laboratorios Almirall, S.A. and Anphar, S.A. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Noverola has collaborated with several professionals in his field, including Jacinto M Mauri and Jose P Soto. These collaborations have likely enriched his research and development efforts, leading to advancements in pharmaceutical chemistry.
Conclusion
Armando V Noverola is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable patents and innovations. His contributions continue to influence the treatment of various medical conditions, showcasing the importance of research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile